CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER

CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER specializes in advanced research and development in the life sciences, with a focused expertise in cancer classification, molecular epidemiology, and translational oncology. The organization conducts international collaborative studies to advance the biological understanding of cancer subtypes, leveraging large-scale cohort data and biospecimen analysis. Their technical capabilities include the design and coordination of multi-center clinical research protocols, urine and tissue sample retrieval systems, and standardized data harmonization for global cancer surveillance. A key differentiator is their capacity to manage complex, cross-border scientific consortia, integrating standardized protocols across diverse geographic and regulatory environments to support precision oncology initiatives. The contractor maintains a consistent partnership with the Department of Health and Human Services, delivering specialized research support for large-scale epidemiological studies, particularly those focused on esophageal and other solid tumor cancers. Their work for HHS centers on high-integrity biospecimen management, longitudinal cohort tracking, and international data sharing frameworks that align with public health research mandates. This relationship reflects a trusted, mission-aligned engagement in advancing population-level cancer research through rigorous scientific methodology. Their primary NAICS classification, 541715, reflects a dedicated focus on non-biotechnology life sciences research, emphasizing fundamental biological inquiry over commercial product development. This positions them as a research-intensive entity within the global public health science ecosystem, specializing in cancer etiology, biomarker discovery, and international data collaboration rather than therapeutic or diagnostic product innovation. The entity is structured as an international research organization headquartered in Lyon, France, with no disclosed government certifications. It operates as a non-commercial, mission-driven institution, engaging exclusively in scientific research and consortium-based collaboration. Its geographic presence is anchored in Europe, with a global footprint enabled through international research partnerships and data-sharing agreements with U.S. and other national health agencies.